Point-of-care testing (POCT) has diverse applications across medical domains, from emergency medicine to chronic disease management. Its rapid results, accessibility, and ability to bring diagnostics closer to the patient enhance healthcare outcomes. In emergency settings, POCT aids in quick decision-making, while in primary care, it facilitates timely diagnosis and personalized treatment. The technology is integral to infectious disease control, offering rapid testing for conditions such as HIV and influenza. Furthermore, point-of-care imaging provides immediate visual diagnostics, and the overall cost-efficiency of POCT, along with improved patient engagement, makes it a valuable tool in modern healthcare. Its role in preventive care, enabling regular monitoring and early detection, underscores the broad impact of POCT on enhancing patient care and healthcare system efficiency.
According to Data Bridge Market Research analyses that the Global Point-Of-Care Testing (POCT) Market which was USD 29 billion in 2021, would rocket up to USD 64.46 billion by 2029, and is expected to undergo a CAGR of 10.5% during the forecast period 2022 to 2029.
"Benefits Related With OTC-Based Test Boosts the Market Growth"
The growth of the point-of-care testing (POCT) market for time-critical tests is fueled by the increasing popularity of over-the-counter (OTC) testing, such as pregnancy and blood glucose tests. OTC tests offer accessibility, convenience, and rapid results, often within seconds. Their user-friendly design allows individuals to perform tests without the need for specialized expertise, reducing dependency on healthcare professionals and eliminating the need for facility visits. Successful products such as the First Response pregnancy test and Accu-Chek active blood glucose meter kits exemplify the effectiveness and popularity of OTC tests, setting a positive precedent in the market. The projected 7.1% CAGR through 2027 underscores the significant role of OTC testing as a key driver in propelling the POCT market forward.
What restraints the growth of global point-of-care testing (POCT) market?
"Lack of alignment with definitive central lab methods"
Pre-analytical errors, including a lack of alignment with central lab methods, unsuitable indications, inappropriate sampling practices, insufficient patient information, and neglect of factors such as fasting or posture variations, collectively serve as significant restraints in the point-of-care (POC) testing market. These issues undermine the confidence of healthcare providers in the accuracy and reliability of POC test results. The misalignment with established laboratory standards, limited applicability for specific indications, and concerns about procedural precision hinder the widespread adoption of POC testing solutions.
Segmentation: Global Point-Of-Care Testing (POCT) Market
The global point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application, end-user and distribution channel.
- On the basis of product, the global point-of-care testing (POCT) market is segmented glucose monitoring products, cardiometabolic testing products, infectious disease testing products, pregnancy and fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drugs-of-abuse testing products, fecal occult testing products, rapid coagulation testing and other poc products
- On the basis of application, the global point-of-care testing (POCT) market is segmented into blood transfusion, cardiac monitoring, coagulation, blood glucose, haematology, non- invasive spo2 monitoring, non- invasive pco2 monitoring, whole blood analysis, vital sign monitoring and others
- On the basis of platform, the global point-of-care testing (POCT) market is segmented into lateral flow assays/immunochromatography tests, dipsticks, microfluidics, molecular diagnostics and immunoassays
- On the basis of prescription mode, the global point-of-care testing (POCT) market is segmented into prescription-based testing and OTC testing
- On the basis of testing type, the global point-of-care testing (POCT) market is segmented into immunoassays, cell-based assays, nucleic acid amplification testing, clinical chemistry assays and hematology
- On the basis of end-user, the global point-of-care testing (POCT) market into hospitals, clinics, laboratories, home care, ambulatory surgery centers and others
- On the basis of distribution channel the global point-of-care testing (POCT) market is segmented into direct tender and retail pharmacies
To know more about the study visit, https://www.databridgemarketresearch.com/reports/point-care-testing-poct-market
Recent Developments in Global Point-Of-Care Testing (POCT) Market
- In January 2022, Roche Diagnostics launched the Cobas Pulse System, the newest iteration of its connected point-of-care solutions for professional blood glucose management, in select CE Mark-accepting countries.
- In October 2021, Thermo Fisher Scientific secured FDA Emergency Use Authorization (EUA) for COVID-19 testing using the SpectrumDNA SDNA-1000 collection device. The high-throughput, automated COVID-19 testing system, known as the Amplitude Solution, incorporates a novel saliva sample collection method.
The Prominent Key Players Operating in the Global Point-Of-Care Testing (POCT) Market Include:
- Abbott (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BD (U.S.)
- Siemens Healthcare Private Limited (Germany)
- Bio-Rad Laboratories, Inc. (U.S.)
- Danaher (U.S.)
- Sekisui Diagnostics (U.S.)
- Trinity Biotech (Ireland)
- bioMérieux (France)
- EKF Diagnostics (Germany)
- AccuBioTech Co., Ltd. (China)
- Instrumentation Laboratory (U.S.)
- Beckman Coulter, Inc. (U.S.)
- PTS Diagnostics (U.S.)
- Nova Biomedical (U.S.)
- Chembio Diagnostics, Inc. (U.S.)
- Quidel Corporation (U.S.)
- Sienco, Inc (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global point-of-care testing (POCT) market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Point-Of-Care Testing (POCT) Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
